NDC 59148-046

Dacogen

Decitabine

Dacogen is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is Decitabine.

Product ID59148-046_4d5b6a30-b467-4236-bef9-4c339aab5921
NDC59148-046
Product TypeHuman Prescription Drug
Proprietary NameDacogen
Generic NameDecitabine
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2006-05-02
Marketing CategoryNDA / NDA
Application NumberNDA021790
Labeler NameOtsuka America Pharmaceutical, Inc.
Substance NameDECITABINE
Active Ingredient Strength50 mg/20mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 59148-046-70

1 VIAL in 1 CARTON (59148-046-70) > 20 mL in 1 VIAL
Marketing Start Date2006-05-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59148-046-70 [59148004670]

Dacogen INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA021790
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-05-02

Drug Details

Active Ingredients

IngredientStrength
DECITABINE50 mg/20mL

OpenFDA Data

SPL SET ID:deb4a13c-855b-4372-9778-6e81da598df6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 644989
  • 636631
  • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "Dacogen" or generic name "Decitabine"

    NDCBrand NameGeneric Name
    59148-046Dacogendecitabine
    0143-9385decitabinedecitabine
    0781-3139DecitabineDecitabine
    0781-3296DecitabineDecitabine
    16714-749DecitabineDecitabine
    16714-928DecitabineDecitabine
    16729-224Decitabinedecitabine
    25021-231decitabinedecitabine
    42737-110DecitabineDecitabine
    43598-348DecitabineDecitabine
    43598-427DecitabineDecitabine
    47335-361decitabinedecitabine
    50742-430DECITABINEdecitabine
    55111-556DecitabineDecitabine
    55150-376DecitabineDecitabine

    Trademark Results [Dacogen]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DACOGEN
    DACOGEN
    78216191 3197209 Live/Registered
    ASTEX PHARMACEUTICALS, INC.
    2003-02-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.